Hungary: January Drug Prices Rises

12 November 1997

Hungary's Welfare Ministry has announced that retail prices of medicinesin the country will increase by an average of 10.8% in January, with a detailed list of new pharmaceutical prices to be published during December, reports MTO Econews. The Ministry added that the average increase in the consumer price of medicines this year is likely to have been less than 10%.

A total of 4,000 pharmaceutical products are currently available on the Hungarian market, of which 1,000 are used exclusively in hospitals. Of the 3,000 products sold outside hospitals, the National Health Fund subsidizes around 1,500 at subsidy rates of 0%, 50%, 70%, 90% and 100%.

The subsidy rates will remain unchanged in 1998, but a total of 1,288 medicines will no longer be subsidized, as manufacturers and wholesalers have not applied for price subsidies on them.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight